EP. 1: Axial Spondyloarthritis Defined
Watch
EP. 2: Epidemiology of Axial Spondyloarthritis
EP. 3: Accurately Diagnosing Axial Spondyloarthritis
EP. 4: Unmet Needs in the Diagnosis of Axial Spondyloarthritis
EP. 5: Axial Spondyloarthritis and Quality of Life
EP. 6: Establishing Goals of Therapy in Axial Spondyloarthritis
EP. 7: Clinical Recommendations: Managing Axial Spondyloarthritis
EP. 8: Treating Axial Spondyloarthritis
EP. 9: Axial Spondyloarthritis: Future Outlook
EP. 10: Initial Symptoms of NrAxSpa & Inconclusive Diagnostics
EP. 11: Timeline of NrAxSpa Onset to Correct Diagnosis
EP. 12: Ineffective NrAxSpa Treatments
EP. 13: Living With Untreated NrAxSpa
EP. 14: The Progression of Nr-AxSpA Symptoms
EP. 15: The Impact of Certolizumab Pegol in Treating Nr-AxSpA
EP. 16: Living With NrAxSpa Posttreatment
EP. 17: The IFAA: Raising Awareness of NrAxSpa & Related Diseases
EP. 18: Advice for NrAxSpa Patients & Future of Treatment
EP. 19: Nonradiographic Versus Radiographic Axial Spondyloarthritis
EP. 20: The Epidemiology of Axial Spondyloarthritis
EP. 21: Diagnosing Axial Spondyloarthritis
EP. 22: AxSpa Treatment Goals and Windows of Opportunity
EP. 23: AxSpa Treatments: TNF Inhibitors, NSAIDs, and Opioids
EP. 24: The Future of Axial Spondyloarthritis Treatment